1h Free Analyst Time
The global human chorionic gonadotropin (hcg) market is forecasted to grow by USD 208.6 million during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the global human chorionic gonadotropin (hcg) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of infertility and expanding utilization of art, technological advancements and product innovation in biopharmaceutical production, expanding therapeutic applications and growing off-label usage.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global human chorionic gonadotropin (hcg) market is segmented as below:
By Technology
- Natural source extraction
- Recombinant technology
By End-User
- Clinics
- Hospitals
- Diagnostic laboratories
By Route Of Administration
- Injectable
- Oral
- Nasal spray
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
The report on the global human chorionic gonadotropin (hcg) market covers the following areas:
- Global human chorionic gonadotropin (hcg) market sizing
- Global human chorionic gonadotropin (hcg) market forecast
- Global human chorionic gonadotropin (hcg) market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2024-2029
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Human Chorionic Gonadotropin (HCG) Market 2019 - 2023
- Historic Market Size - Data Table on Global Human Chorionic Gonadotropin (HCG) Market 2019 - 2023 ($ million)
- Historic Market Size - Technology Segment 2019 - 2023 ($ million)
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The Impact of AI on the Global Human Chorionic Gonadotropin (HCG) Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- Threat of new entrants - Impact of key factors in 2024 and 2029
- Threat of substitutes - Impact of key factors in 2024 and 2029
- Threat of rivalry - Impact of key factors in 2024 and 2029
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Technology
8.1 Market segments
- Chart on Technology - Market share 2024-2029 (%)
- Data Table on Technology - Market share 2024-2029 (%)
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
- Chart on Natural source extraction - Market size and forecast 2024-2029 ($ million)
- Data Table on Natural source extraction - Market size and forecast 2024-2029 ($ million)
- Chart on Natural source extraction - Year-over-year growth 2024-2029 (%)
- Data Table on Natural source extraction - Year-over-year growth 2024-2029 (%)
- Chart on Recombinant technology - Market size and forecast 2024-2029 ($ million)
- Data Table on Recombinant technology - Market size and forecast 2024-2029 ($ million)
- Chart on Recombinant technology - Year-over-year growth 2024-2029 (%)
- Data Table on Recombinant technology - Year-over-year growth 2024-2029 (%)
- Market opportunity by Technology ($ million)
- Data Table on Market opportunity by Technology ($ million)
9 Market Segmentation by End-user
9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Clinics - Year-over-year growth 2024-2029 (%)
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
- Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
- Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
- Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Injectable - Market size and forecast 2024-2029 ($ million)
- Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
- Chart on Injectable - Year-over-year growth 2024-2029 (%)
- Data Table on Injectable - Year-over-year growth 2024-2029 (%)
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
- Chart on Nasal spray - Market size and forecast 2024-2029 ($ million)
- Data Table on Nasal spray - Market size and forecast 2024-2029 ($ million)
- Chart on Nasal spray - Year-over-year growth 2024-2029 (%)
- Data Table on Nasal spray - Year-over-year growth 2024-2029 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- Chart on Spain - Market size and forecast 2024-2029 ($ million)
- Data Table on Spain - Market size and forecast 2024-2029 ($ million)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- Chart on Thailand - Market size and forecast 2024-2029 ($ million)
- Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
- Chart on Thailand - Year-over-year growth 2024-2029 (%)
- Data Table on Thailand - Year-over-year growth 2024-2029 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Chart on Argentina - Market size and forecast 2024-2029 ($ million)
- Data Table on Argentina - Market size and forecast 2024-2029 ($ million)
- Chart on Argentina - Year-over-year growth 2024-2029 (%)
- Data Table on Argentina - Year-over-year growth 2024-2029 (%)
- Chart on Colombia - Market size and forecast 2024-2029 ($ million)
- Data Table on Colombia - Market size and forecast 2024-2029 ($ million)
- Chart on Colombia - Year-over-year growth 2024-2029 (%)
- Data Table on Colombia - Year-over-year growth 2024-2029 (%)
- Chart on UAE - Market size and forecast 2024-2029 ($ million)
- Data Table on UAE - Market size and forecast 2024-2029 ($ million)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- Chart on South Africa - Market size and forecast 2024-2029 ($ million)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- Chart on Turkey - Market size and forecast 2024-2029 ($ million)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- Chart on Israel - Market size and forecast 2024-2029 ($ million)
- Data Table on Israel - Market size and forecast 2024-2029 ($ million)
- Chart on Israel - Year-over-year growth 2024-2029 (%)
- Data Table on Israel - Year-over-year growth 2024-2029 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Rising global prevalence of infertility and expanding utilization of ART
- Technological advancements and product innovation in biopharmaceutical production
- Expanding therapeutic applications and growing off-label usage
- Regulatory hurdles and biosimilar conundrum
- Intensifying threat of product diversion and illicit use
- Supply chain vulnerabilities and raw material sourcing constraints
- Impact of drivers and challenges in 2024 and 2029
- Emerging trend of delayed pregnancies among women coupled with expanding ART centers
- Strategic product approvals and intensifying pharmaceutical sector engagement
- Growing disposable income and healthcare expenditure in emerging economies
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- Corona Remedies Pvt. Ltd. - Overview
- Corona Remedies Pvt. Ltd. - Product / Service
- Corona Remedies Pvt. Ltd. - Key offerings
- SWOT
- Emcure Pharmaceuticals Ltd. - Overview
- Emcure Pharmaceuticals Ltd. - Product / Service
- Emcure Pharmaceuticals Ltd. - Key offerings
- SWOT
- Ferring BV - Overview
- Ferring BV - Product / Service
- Ferring BV - Key news
- Ferring BV - Key offerings
- SWOT
- Fresenius Kabi AG - Overview
- Fresenius Kabi AG - Product / Service
- Fresenius Kabi AG - Key offerings
- SWOT
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
- SWOT
- Lee BioSolutions Inc - Overview
- Lee BioSolutions Inc - Product / Service
- Lee BioSolutions Inc - Key offerings
- SWOT
- Lijun Pharmaceutical Group Co., Ltd. - Overview
- Lijun Pharmaceutical Group Co., Ltd. - Product / Service
- Lijun Pharmaceutical Group Co., Ltd. - Key offerings
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Ningbo Renjian Pharmaceutical Group Co., Ltd - Overview
- Ningbo Renjian Pharmaceutical Group Co., Ltd - Product / Service
- Ningbo Renjian Pharmaceutical Group Co., Ltd - Key offerings
- SWOT
- Organon and Co. - Overview
- Organon and Co. - Product / Service
- Organon and Co. - Key offerings
- SWOT
- Sanzyme Pvt. Ltd. - Overview
- Sanzyme Pvt. Ltd. - Product / Service
- Sanzyme Pvt. Ltd. - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2024 and 2029
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 25: Historic Market Size - Data Table on Global Human Chorionic Gonadotropin (HCG) Market 2019 - 2023 ($ million)
Exhibit 26: Historic Market Size - Technology Segment 2019 - 2023 ($ million)
Exhibit 27: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2024 and 2029
Exhibit 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibit 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibit 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibit 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibit 37: Chart on Market condition - Five forces 2024 and 2029
Exhibit 38: Chart on Technology - Market share 2024-2029 (%)
Exhibit 39: Data Table on Technology - Market share 2024-2029 (%)
Exhibit 40: Chart on Comparison by Technology
Exhibit 41: Data Table on Comparison by Technology
Exhibit 42: Chart on Natural source extraction - Market size and forecast 2024-2029 ($ million)
Exhibit 43: Data Table on Natural source extraction - Market size and forecast 2024-2029 ($ million)
Exhibit 44: Chart on Natural source extraction - Year-over-year growth 2024-2029 (%)
Exhibit 45: Data Table on Natural source extraction - Year-over-year growth 2024-2029 (%)
Exhibit 46: Chart on Recombinant technology - Market size and forecast 2024-2029 ($ million)
Exhibit 47: Data Table on Recombinant technology - Market size and forecast 2024-2029 ($ million)
Exhibit 48: Chart on Recombinant technology - Year-over-year growth 2024-2029 (%)
Exhibit 49: Data Table on Recombinant technology - Year-over-year growth 2024-2029 (%)
Exhibit 50: Market opportunity by Technology ($ million)
Exhibit 51: Data Table on Market opportunity by Technology ($ million)
Exhibit 52: Chart on End-user - Market share 2024-2029 (%)
Exhibit 53: Data Table on End-user - Market share 2024-2029 (%)
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
Exhibit 56: Chart on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 57: Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 58: Chart on Clinics - Year-over-year growth 2024-2029 (%)
Exhibit 59: Data Table on Clinics - Year-over-year growth 2024-2029 (%)
Exhibit 60: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibit 61: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibit 62: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibit 63: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibit 64: Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
Exhibit 65: Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
Exhibit 66: Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Exhibit 67: Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Exhibit 68: Market opportunity by End-user ($ million)
Exhibit 69: Data Table on Market opportunity by End-user ($ million)
Exhibit 70: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibit 71: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibit 72: Chart on Comparison by Route of Administration
Exhibit 73: Data Table on Comparison by Route of Administration
Exhibit 74: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibit 75: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibit 76: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibit 77: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibit 78: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibit 79: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibit 80: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibit 81: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibit 82: Chart on Nasal spray - Market size and forecast 2024-2029 ($ million)
Exhibit 83: Data Table on Nasal spray - Market size and forecast 2024-2029 ($ million)
Exhibit 84: Chart on Nasal spray - Year-over-year growth 2024-2029 (%)
Exhibit 85: Data Table on Nasal spray - Year-over-year growth 2024-2029 (%)
Exhibit 86: Market opportunity by Route of Administration ($ million)
Exhibit 87: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2024-2029 (%)
Exhibit 90: Data Table on Market share by geography 2024-2029 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibit 96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibit 97: Chart on Regional Comparison - North America
Exhibit 98: Data Table on Regional Comparison - North America
Exhibit 99: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 107: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 108: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 109: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 110: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 111: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 112: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 113: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 114: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 115: Chart on Regional Comparison - Europe
Exhibit 116: Data Table on Regional Comparison - Europe
Exhibit 117: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 118: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 119: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 120: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 121: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 122: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 123: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibit 124: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibit 125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibit 126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibit 127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibit 128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibit 129: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 130: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 131: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 132: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 133: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 134: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 135: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 136: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 137: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 138: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 139: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 140: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 141: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 142: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 143: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 144: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 145: Chart on Regional Comparison - Asia
Exhibit 146: Data Table on Regional Comparison - Asia
Exhibit 147: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibit 148: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibit 149: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibit 150: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibit 151: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 152: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 153: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 154: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 155: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibit 156: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibit 157: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibit 159: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 160: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 161: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 162: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 163: Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 164: Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 165: Chart on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 166: Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 167: Chart on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 168: Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 169: Chart on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 170: Data Table on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 171: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 172: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 173: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 174: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 175: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 176: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 177: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 178: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 179: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 180: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 181: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 182: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 183: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 184: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 185: Chart on Argentina - Market size and forecast 2024-2029 ($ million)
Exhibit 186: Data Table on Argentina - Market size and forecast 2024-2029 ($ million)
Exhibit 187: Chart on Argentina - Year-over-year growth 2024-2029 (%)
Exhibit 188: Data Table on Argentina - Year-over-year growth 2024-2029 (%)
Exhibit 189: Chart on Colombia - Market size and forecast 2024-2029 ($ million)
Exhibit 190: Data Table on Colombia - Market size and forecast 2024-2029 ($ million)
Exhibit 191: Chart on Colombia - Year-over-year growth 2024-2029 (%)
Exhibit 192: Data Table on Colombia - Year-over-year growth 2024-2029 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 198: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 199: Chart on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 201: Chart on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 202: Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 203: Chart on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 204: Data Table on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2024-2029 ($ million)
Exhibit 206: Data Table on Israel - Market size and forecast 2024-2029 ($ million)
Exhibit 207: Chart on Israel - Year-over-year growth 2024-2029 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2024-2029 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2024 and 2029
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: Abbott Laboratories - Overview
Exhibit 219: Abbott Laboratories - Business segments
Exhibit 220: Abbott Laboratories - Key news
Exhibit 221: Abbott Laboratories - Key offerings
Exhibit 222: Abbott Laboratories - Segment focus
Exhibit 223: SWOT
Exhibit 224: Cipla Inc. - Overview
Exhibit 225: Cipla Inc. - Business segments
Exhibit 226: Cipla Inc. - Key news
Exhibit 227: Cipla Inc. - Key offerings
Exhibit 228: Cipla Inc. - Segment focus
Exhibit 229: SWOT
Exhibit 230: Corona Remedies Pvt. Ltd. - Overview
Exhibit 231: Corona Remedies Pvt. Ltd. - Product / Service
Exhibit 232: Corona Remedies Pvt. Ltd. - Key offerings
Exhibit 233: SWOT
Exhibit 234: Emcure Pharmaceuticals Ltd. - Overview
Exhibit 235: Emcure Pharmaceuticals Ltd. - Product / Service
Exhibit 236: Emcure Pharmaceuticals Ltd. - Key offerings
Exhibit 237: SWOT
Exhibit 238: Ferring BV - Overview
Exhibit 239: Ferring BV - Product / Service
Exhibit 240: Ferring BV - Key news
Exhibit 241: Ferring BV - Key offerings
Exhibit 242: SWOT
Exhibit 243: Fresenius Kabi AG - Overview
Exhibit 244: Fresenius Kabi AG - Product / Service
Exhibit 245: Fresenius Kabi AG - Key offerings
Exhibit 246: SWOT
Exhibit 247: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 248: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 249: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 250: SWOT
Exhibit 251: Intas Pharmaceuticals Ltd. - Overview
Exhibit 252: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 253: Intas Pharmaceuticals Ltd. - Key offerings
Exhibit 254: SWOT
Exhibit 255: Lee BioSolutions Inc - Overview
Exhibit 256: Lee BioSolutions Inc - Product / Service
Exhibit 257: Lee BioSolutions Inc - Key offerings
Exhibit 258: SWOT
Exhibit 259: Lijun Pharmaceutical Group Co., Ltd. - Overview
Exhibit 260: Lijun Pharmaceutical Group Co., Ltd. - Product / Service
Exhibit 261: Lijun Pharmaceutical Group Co., Ltd. - Key offerings
Exhibit 262: SWOT
Exhibit 263: Lupin Ltd. - Overview
Exhibit 264: Lupin Ltd. - Business segments
Exhibit 265: Lupin Ltd. - Key news
Exhibit 266: Lupin Ltd. - Key offerings
Exhibit 267: Lupin Ltd. - Segment focus
Exhibit 268: SWOT
Exhibit 269: Merck and Co. Inc. - Overview
Exhibit 270: Merck and Co. Inc. - Business segments
Exhibit 271: Merck and Co. Inc. - Key news
Exhibit 272: Merck and Co. Inc. - Key offerings
Exhibit 273: Merck and Co. Inc. - Segment focus
Exhibit 274: SWOT
Exhibit 275: Ningbo Renjian Pharmaceutical Group Co., Ltd - Overview
Exhibit 276: Ningbo Renjian Pharmaceutical Group Co., Ltd - Product / Service
Exhibit 277: Ningbo Renjian Pharmaceutical Group Co., Ltd - Key offerings
Exhibit 278: SWOT
Exhibit 279: Organon and Co. - Overview
Exhibit 280: Organon and Co. - Product / Service
Exhibit 281: Organon and Co. - Key offerings
Exhibit 282: SWOT
Exhibit 283: Sanzyme Pvt. Ltd. - Overview
Exhibit 284: Sanzyme Pvt. Ltd. - Product / Service
Exhibit 285: Sanzyme Pvt. Ltd. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Inclusions checklist
Exhibit 288: Exclusions checklist
Exhibit 289: Currency conversion rates for US$
Exhibit 290: Research methodology
Exhibit 291: Information sources
Exhibit 292: Data validation
Exhibit 293: Validation techniques employed for market sizing
Exhibit 294: Data synthesis
Exhibit 295: 360 degree market analysis
Exhibit 296: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2024 and 2029
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 25: Historic Market Size - Data Table on Global Human Chorionic Gonadotropin (HCG) Market 2019 - 2023 ($ million)
Exhibit 26: Historic Market Size - Technology Segment 2019 - 2023 ($ million)
Exhibit 27: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2024 and 2029
Exhibit 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibit 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibit 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibit 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibit 37: Chart on Market condition - Five forces 2024 and 2029
Exhibit 38: Chart on Technology - Market share 2024-2029 (%)
Exhibit 39: Data Table on Technology - Market share 2024-2029 (%)
Exhibit 40: Chart on Comparison by Technology
Exhibit 41: Data Table on Comparison by Technology
Exhibit 42: Chart on Natural source extraction - Market size and forecast 2024-2029 ($ million)
Exhibit 43: Data Table on Natural source extraction - Market size and forecast 2024-2029 ($ million)
Exhibit 44: Chart on Natural source extraction - Year-over-year growth 2024-2029 (%)
Exhibit 45: Data Table on Natural source extraction - Year-over-year growth 2024-2029 (%)
Exhibit 46: Chart on Recombinant technology - Market size and forecast 2024-2029 ($ million)
Exhibit 47: Data Table on Recombinant technology - Market size and forecast 2024-2029 ($ million)
Exhibit 48: Chart on Recombinant technology - Year-over-year growth 2024-2029 (%)
Exhibit 49: Data Table on Recombinant technology - Year-over-year growth 2024-2029 (%)
Exhibit 50: Market opportunity by Technology ($ million)
Exhibit 51: Data Table on Market opportunity by Technology ($ million)
Exhibit 52: Chart on End-user - Market share 2024-2029 (%)
Exhibit 53: Data Table on End-user - Market share 2024-2029 (%)
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
Exhibit 56: Chart on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 57: Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 58: Chart on Clinics - Year-over-year growth 2024-2029 (%)
Exhibit 59: Data Table on Clinics - Year-over-year growth 2024-2029 (%)
Exhibit 60: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibit 61: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibit 62: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibit 63: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibit 64: Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
Exhibit 65: Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
Exhibit 66: Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Exhibit 67: Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Exhibit 68: Market opportunity by End-user ($ million)
Exhibit 69: Data Table on Market opportunity by End-user ($ million)
Exhibit 70: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibit 71: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibit 72: Chart on Comparison by Route of Administration
Exhibit 73: Data Table on Comparison by Route of Administration
Exhibit 74: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibit 75: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibit 76: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibit 77: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibit 78: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibit 79: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibit 80: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibit 81: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibit 82: Chart on Nasal spray - Market size and forecast 2024-2029 ($ million)
Exhibit 83: Data Table on Nasal spray - Market size and forecast 2024-2029 ($ million)
Exhibit 84: Chart on Nasal spray - Year-over-year growth 2024-2029 (%)
Exhibit 85: Data Table on Nasal spray - Year-over-year growth 2024-2029 (%)
Exhibit 86: Market opportunity by Route of Administration ($ million)
Exhibit 87: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2024-2029 (%)
Exhibit 90: Data Table on Market share by geography 2024-2029 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibit 96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibit 97: Chart on Regional Comparison - North America
Exhibit 98: Data Table on Regional Comparison - North America
Exhibit 99: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 107: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 108: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 109: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 110: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 111: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 112: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 113: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 114: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 115: Chart on Regional Comparison - Europe
Exhibit 116: Data Table on Regional Comparison - Europe
Exhibit 117: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 118: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 119: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 120: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 121: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 122: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 123: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibit 124: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibit 125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibit 126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibit 127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibit 128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibit 129: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 130: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 131: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 132: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 133: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 134: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 135: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 136: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 137: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 138: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 139: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 140: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 141: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 142: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 143: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 144: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 145: Chart on Regional Comparison - Asia
Exhibit 146: Data Table on Regional Comparison - Asia
Exhibit 147: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibit 148: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibit 149: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibit 150: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibit 151: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 152: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 153: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 154: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 155: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibit 156: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibit 157: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibit 159: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 160: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 161: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 162: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 163: Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 164: Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 165: Chart on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 166: Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 167: Chart on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 168: Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 169: Chart on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 170: Data Table on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 171: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 172: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 173: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 174: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 175: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 176: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 177: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 178: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 179: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 180: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 181: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 182: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 183: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 184: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 185: Chart on Argentina - Market size and forecast 2024-2029 ($ million)
Exhibit 186: Data Table on Argentina - Market size and forecast 2024-2029 ($ million)
Exhibit 187: Chart on Argentina - Year-over-year growth 2024-2029 (%)
Exhibit 188: Data Table on Argentina - Year-over-year growth 2024-2029 (%)
Exhibit 189: Chart on Colombia - Market size and forecast 2024-2029 ($ million)
Exhibit 190: Data Table on Colombia - Market size and forecast 2024-2029 ($ million)
Exhibit 191: Chart on Colombia - Year-over-year growth 2024-2029 (%)
Exhibit 192: Data Table on Colombia - Year-over-year growth 2024-2029 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 198: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 199: Chart on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 201: Chart on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 202: Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 203: Chart on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 204: Data Table on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2024-2029 ($ million)
Exhibit 206: Data Table on Israel - Market size and forecast 2024-2029 ($ million)
Exhibit 207: Chart on Israel - Year-over-year growth 2024-2029 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2024-2029 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2024 and 2029
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: Abbott Laboratories - Overview
Exhibit 219: Abbott Laboratories - Business segments
Exhibit 220: Abbott Laboratories - Key news
Exhibit 221: Abbott Laboratories - Key offerings
Exhibit 222: Abbott Laboratories - Segment focus
Exhibit 223: SWOT
Exhibit 224: Cipla Inc. - Overview
Exhibit 225: Cipla Inc. - Business segments
Exhibit 226: Cipla Inc. - Key news
Exhibit 227: Cipla Inc. - Key offerings
Exhibit 228: Cipla Inc. - Segment focus
Exhibit 229: SWOT
Exhibit 230: Corona Remedies Pvt. Ltd. - Overview
Exhibit 231: Corona Remedies Pvt. Ltd. - Product / Service
Exhibit 232: Corona Remedies Pvt. Ltd. - Key offerings
Exhibit 233: SWOT
Exhibit 234: Emcure Pharmaceuticals Ltd. - Overview
Exhibit 235: Emcure Pharmaceuticals Ltd. - Product / Service
Exhibit 236: Emcure Pharmaceuticals Ltd. - Key offerings
Exhibit 237: SWOT
Exhibit 238: Ferring BV - Overview
Exhibit 239: Ferring BV - Product / Service
Exhibit 240: Ferring BV - Key news
Exhibit 241: Ferring BV - Key offerings
Exhibit 242: SWOT
Exhibit 243: Fresenius Kabi AG - Overview
Exhibit 244: Fresenius Kabi AG - Product / Service
Exhibit 245: Fresenius Kabi AG - Key offerings
Exhibit 246: SWOT
Exhibit 247: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 248: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 249: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 250: SWOT
Exhibit 251: Intas Pharmaceuticals Ltd. - Overview
Exhibit 252: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 253: Intas Pharmaceuticals Ltd. - Key offerings
Exhibit 254: SWOT
Exhibit 255: Lee BioSolutions Inc - Overview
Exhibit 256: Lee BioSolutions Inc - Product / Service
Exhibit 257: Lee BioSolutions Inc - Key offerings
Exhibit 258: SWOT
Exhibit 259: Lijun Pharmaceutical Group Co., Ltd. - Overview
Exhibit 260: Lijun Pharmaceutical Group Co., Ltd. - Product / Service
Exhibit 261: Lijun Pharmaceutical Group Co., Ltd. - Key offerings
Exhibit 262: SWOT
Exhibit 263: Lupin Ltd. - Overview
Exhibit 264: Lupin Ltd. - Business segments
Exhibit 265: Lupin Ltd. - Key news
Exhibit 266: Lupin Ltd. - Key offerings
Exhibit 267: Lupin Ltd. - Segment focus
Exhibit 268: SWOT
Exhibit 269: Merck and Co. Inc. - Overview
Exhibit 270: Merck and Co. Inc. - Business segments
Exhibit 271: Merck and Co. Inc. - Key news
Exhibit 272: Merck and Co. Inc. - Key offerings
Exhibit 273: Merck and Co. Inc. - Segment focus
Exhibit 274: SWOT
Exhibit 275: Ningbo Renjian Pharmaceutical Group Co., Ltd - Overview
Exhibit 276: Ningbo Renjian Pharmaceutical Group Co., Ltd - Product / Service
Exhibit 277: Ningbo Renjian Pharmaceutical Group Co., Ltd - Key offerings
Exhibit 278: SWOT
Exhibit 279: Organon and Co. - Overview
Exhibit 280: Organon and Co. - Product / Service
Exhibit 281: Organon and Co. - Key offerings
Exhibit 282: SWOT
Exhibit 283: Sanzyme Pvt. Ltd. - Overview
Exhibit 284: Sanzyme Pvt. Ltd. - Product / Service
Exhibit 285: Sanzyme Pvt. Ltd. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Inclusions checklist
Exhibit 288: Exclusions checklist
Exhibit 289: Currency conversion rates for US$
Exhibit 290: Research methodology
Exhibit 291: Information sources
Exhibit 292: Data validation
Exhibit 293: Validation techniques employed for market sizing
Exhibit 294: Data synthesis
Exhibit 295: 360 degree market analysis
Exhibit 296: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global human chorionic gonadotropin (hcg) market: Abbott Laboratories, Cipla Inc., Corona Remedies Pvt. Ltd., Emcure Pharmaceuticals Ltd., Ferring BV, Fresenius Kabi AG, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lee BioSolutions Inc, Lijun Pharmaceutical Group Co., Ltd., Lupin Ltd., Merck and Co. Inc., Ningbo Renjian Pharmaceutical Group Co., Ltd, Organon and Co., Sanzyme Pvt. Ltd., Scripps Laboratories Inc., Serum Institute of India Ltd., Sun Pharmaceutical Industries Ltd., The Cigna Group, Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emerging trend of delayed pregnancies among women coupled with expanding art centers."
According to the report, one of the major drivers for this market is the rising global prevalence of infertility and expanding utilization of art.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Cipla Inc.
- Corona Remedies Pvt. Ltd.
- Emcure Pharmaceuticals Ltd.
- Ferring BV
- Fresenius Kabi AG
- Glenmark Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd.
- Lee BioSolutions Inc
- Lijun Pharmaceutical Group Co.
- Ltd.
- Lupin Ltd.
- Merck and Co. Inc.
- Ningbo Renjian Pharmaceutical Group Co.
- Ltd
- Organon and Co.
- Sanzyme Pvt. Ltd.
- Scripps Laboratories Inc.
- Serum Institute of India Ltd.
- Sun Pharmaceutical Industries Ltd.
- The Cigna Group
- Zydus Lifesciences Ltd.
